Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate versus etomidate-based anesthesia for off-pump coronary artery bypass grafting
ChiCTR2400079615Phase 4Not yet recruiting
- Sponsor
- Zibo City Central Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in coronary arteriosclerosis (2 arms), sponsored by Zibo City Central Hospital. Primary endpoint: Fluctuation of mean arterial pressure during induction period. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2400079615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079615.